An RNA-sequencing (RNA-Seq) experiment addressed changes in protease mRNA expression upon short-term PI3K inhibition by the pan-class I PI3K-inhibitor BKM at EC50 in human MCF7 and MDA-MB-231 as well as in murine PyB6-313 breast cancer cells (Figure 1A). Here, PIK3CA is linked to breast carcinoma.